Mesenchymal stromal cells for the prophylaxis and treatment of graft-versus-host disease-a meta-analysis.

Stem Cell Res Ther · 2020 · PMC7027118 · PMID 32070420

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The analysis of five studies containing data for the OS of both control and MSC groups showed a trend to a higher OS for patients infused with MSC (RR = 1.33; 95% CI, 0.84–2.10, I 2 = 51%, Figure S8 B, pp. 11).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.